Diabetic management: Subcutaneous insulin therapy fails to protect against oxidative stress and inflammation

Posted · Add Comment

Today, the gold standard for insulin therapy is the subcutaneous injection of insulin (CSII), despite a non-physiological route of administration with suboptimal glycemic control showed in some patients. Inability of CSII therapy to prevent inflammation and oxidative stress was firstly demonstrated in vivo on treated-diabetic rats, presenting a high variability of glycogen storage associated with glycemic fluctuations. This study suggests that targeting oxidative stress and/or inflammation could help the therapeutic management of diabetic patients.

This full article appears on <a href="https://www.sciencedaily.com/releases/2016/02/160229182551.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *